MLEC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Moolec Science SA (MLEC) is not a strong buy at the moment for a beginner, long-term investor. The stock lacks clear positive trading signals, and while revenue growth is impressive, the company is still operating at a significant net loss with declining gross margins. Additionally, there are no significant catalysts or trends to suggest immediate upside potential.
The MACD is positive and contracting, indicating a potential slowdown in momentum. The RSI is neutral at 70.5, and moving averages are converging, suggesting no strong directional trend. Key support and resistance levels show a wide range, with the pivot at 13.759, R1 at 20.864, and S1 at 6.653, indicating potential volatility.
Revenue increased significantly by 948.32% YoY in Q2 2025, showing strong growth potential. The MACD remains positive, which could indicate bullish momentum if sustained.
The company is still operating at a net loss of -2427307, with gross margins dropping to -25.78%. Pre-market price is down 3.26%, and there are no significant insider or hedge fund trading trends. No recent congress trading data or valuation data is available.
In Q2 2025, revenue increased by 948.32% YoY, and net income improved by 36.10% YoY. However, the company remains unprofitable, with a net loss of -2427307 and a gross margin decline of -133.20% YoY. EPS also remains negative at -9.35.
No data available for analyst ratings or price target changes.
